PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Korea Research Institute OF Bioscience AND Biotechnology

USPTO PatentsView assignee record - 168 granted patents across 53 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Explore the portfolio See the ranking
168
Total patents granted
53
CPC technology areas
9.3
Avg claims per patent
-59%
5-year filing velocity

The verdict

Korea holds 168 US patents across 53 technology areas, rank #2,330 of 50,000 tracked assignees.

#2,330
of 50,000 US assignees by volume
Top 12%
by Innovation Score (50.8/100)
9.3
avg claims per patent
-59%
filing velocity, last 5 yrs

Portfolio overview

Korea Research Institute OF Bioscience AND Biotechnology has been granted 168 US utility patents between 2015 and 2025, placing Korea Research Institute OF Bioscience AND Biotechnology at rank #2,330 across all assignees tracked by PlainPatent. This portfolio spans 53 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Korea Research Institute OF Bioscience AND Biotechnology is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Korea sits between Extreme Networks, Inc. (168 patents, rank #2,326) and Oerlikon Surface Solutions Ag, Pfäffikon (168 patents, rank #2,334) - the closest US assignees by grant volume. The composite Innovation Score of 50.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 49 grants, compared with 119 in the 2015–2019 window, a -59% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Korea Research Institute OF Bioscience AND Biotechnology's 9.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 53 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Korea Research Institute OF Bioscience AND Biotechnology against peers pursuing similar technology classes.

Who files at Korea's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Korea holds 168 patents at rank #2,330, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Korea

By rank, the assignees closest to #2,330 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Korea's primary technology class.

Korea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20152016201720182019202020212022202320242025 14
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Korea Research Institute OF Bioscience AND Biotechnology patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 29 17.3%
2016 26 15.5%
2017 26 15.5%
2018 21 12.5%
2019 17 10.1%
2020 13 7.7%
2021 8 4.8%
2022 4 2.4%
2023 5 3.0%
2024 5 3.0%
2025 14 8.3%

Which technologies does Korea Research Institute OF Bioscience AND Biotechnology patent most?

Top 15 of 53 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Declining

Where it ranks

Overall rank by patents

#2,330

Across all tracked assignees

Innovation Score

50.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Korea Research Institute OF Bioscience AND Biotechnology hold?
Korea Research Institute OF Bioscience AND Biotechnology holds 168 US granted patents filed between 2015 and 2025, spanning 53 technology areas.
What is Korea Research Institute OF Bioscience AND Biotechnology's Innovation Score?
Korea Research Institute OF Bioscience AND Biotechnology has an Innovation Score of 50.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Korea Research Institute OF Bioscience AND Biotechnology focus on?
Korea Research Institute OF Bioscience AND Biotechnology's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 92 patents. The company has filed patents in 53 CPC subclasses total.
Is Korea Research Institute OF Bioscience AND Biotechnology's patent filing rate increasing or decreasing?
Korea Research Institute OF Bioscience AND Biotechnology's recent filing velocity is -59% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Korea Research Institute OF Bioscience AND Biotechnology's patents?
Korea Research Institute OF Bioscience AND Biotechnology's patents average 9.3 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Korea Research Institute OF Bioscience AND Biotechnology patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Korea's 168 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Korea ranks #2,330 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.